Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950134-07-010833
Filing Date
2007-05-09
Accepted
2007-05-09 13:05:31
Documents
1
Group Members
MPM ASSET MANAGEMENT INVESTORS 2005 BVIII LLCMPM BIOVENTURES III GMBH & CO BETEILIGUNGS KGMPM BIOVENTURES III GP LPMPM BIOVENTURES III LLCMPM BIOVENTURES III PARALLEL FUND LPMPM BIOVENTURES III QP LP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13D f30160a2sc13dza.htm SC 13D/A 167452
  Complete submission text file 0000950134-07-010833.txt   169948
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
PONIARD PHARMACEUTICALS, INC. (Subject) CIK: 0000755806 (see all company filings)

EIN.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-40119 | Film No.: 07831421
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 5TH FLOOR BOSTON MA 02116
Business Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 5TH FLOOR BOSTON MA 02116 617 425 9200
MPM BIOVENTURES III LP (Filed by) CIK: 0001173408 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A